Targeting translation initiation in breast cancer

Translation
Argun AkcakanatFunda Meric-Bernstam

Abstract

Over the past 20 years, a better understanding of cancer biology, screening for early detection, improved adjuvant treatment, and targeted therapies have decreased the rate of breast cancer deaths. However, resistance to treatment is common, and new approaches are needed. Deregulation of translation initiation is associated with the commencement and progression of cancer. Often, translation initiation factors are overexpressed and the related signaling pathways activated in human tumors. Recently, a significant number of inhibitors that target translation factors and pathways have become available. These inhibitors are being tested alone or in combination with chemotherapeutic agents in clinical trials. The results are varied, and it is not yet clear which drug treatments most effectively inhibit tumor growth. This review highlights the pathways and downstream effects of the activation of translation and discusses targeting the control of translation initiation as a therapeutic approach in cancer, focusing on breast cancer clinical trials.

References

Jan 1, 1977·European Journal of Biochemistry·M FresnoD Vázquez
Mar 1, 1990·Molecular and Cellular Biology·F RozenN Sonenberg
Jun 16, 1995·The Journal of Biological Chemistry·B JoshiR E Rhoads
May 2, 1997·International Journal of Cancer. Journal International Du Cancer·J EberleC E Orfanos
Dec 16, 1997·International Journal of Cancer. Journal International Du Cancer·A A AlaiyaG Auer
Aug 14, 1998·Molecular Cell·S E WellsA B Sachs
Jun 29, 2000·Annual Review of Biochemistry·A C GingrasN Sonenberg
Jul 19, 2000·Current Biology : CB·T P HerbertC G Proud
Oct 26, 2000·Trends in Genetics : TIG·M HolcikR G Korneluk
Nov 14, 2000·The American Journal of Pathology·M RotheN Wernert
May 1, 2002·Annals of Surgery·Benjamin D L LiArrigo DeBenedetti
Jul 13, 2002·International Journal of Cancer. Journal International Du Cancer·Paul M J ClementMyung Hee Park
Aug 13, 2002·Nature Cell Biology·Ken InokiKun-Liang Guan
Nov 21, 2002·The Journal of Biological Chemistry·Shunan LiVitaly A Polunovsky
Sep 16, 2003·Molecular Biology of the Cell·Zizheng Dong, Jian-Ting Zhang
Apr 20, 2004·Oncogene·Arrigo De Benedetti, Jeremy R Graff
May 5, 2004·The Journal of Biological Chemistry·Kyle W SherrillRichard E Lloyd
Oct 27, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wallace H MondesireFunda Meric-Bernstam
Dec 17, 2004·Proceedings of the National Academy of Sciences of the United States of America·Alex KentsisKatherine L B Borden
Jul 21, 2005·Proceedings of the National Academy of Sciences of the United States of America·Marie-Eve BordeleauJerry Pelletier
Jul 22, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Anne BoulayHeidi A Lane
Aug 6, 2005·Science·Ramesh S PillaiWitold Filipowicz
Mar 15, 2006·Nature Chemical Biology·Marie-Eve BordeleauJerry Pelletier
Mar 17, 2006·Cancer Research·Hao WuWilliam N Hait
Jun 13, 2006·The Journal of Biological Chemistry·Aaron K LeFebvreRobert E Rhoads

❮ Previous
Next ❯

Citations

Jul 9, 2004·Biochimica Et Biophysica Acta·Mohamed Abdelhaleem

❮ Previous
Next ❯

Methods Mentioned

BETA
antisense
xenografts
antisense oligonucleotide
antisense oligonucleotides
xenograft

Related Concepts

Related Feeds

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.